Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-07-001084
Filing Date
2007-03-14
Accepted
2007-03-14 06:04:21
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w31820e10vk.htm 10-K 1301634
2 EX-10.22 w31820exv10w22.htm EX-10.22 2212
3 EX-21.1 w31820exv21w1.htm EX-21.1 1385
4 EX-23.1 w31820exv23w1.htm EX-23.1 4256
5 EX-31.1 w31820exv31w1.htm EX-31.1 9249
6 EX-31.2 w31820exv31w2.htm EX-31.2 9289
7 EX-32.1 w31820exv32w1.htm EX-32.1 4418
8 EX-32.2 w31820exv32w2.htm EX-32.2 4705
9 GRAPHIC w31820w3182001.gif GRAPHIC 9073
  Complete submission text file 0000950133-07-001084.txt   1351062
Mailing Address
Business Address 1881 GROVE AVENUE RADFORD VA 24141 5406337900
NEW RIVER PHARMACEUTICALS INC (Filer) CIK: 0001288379 (see all company filings)

EIN.: 541816479 | State of Incorp.: VA
Type: 10-K | Act: 34 | File No.: 000-50851 | Film No.: 07692111
SIC: 2834 Pharmaceutical Preparations